Your session is about to expire
← Back to Search
Erector Spinae Plane Block for Cesarean Section Complications (ESPCS Trial)
ESPCS Trial Summary
This trial is testing whether the Erector Spinae Plane Block is more effective than intrathecal morphine for post-cesarean delivery pain relief.
ESPCS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowESPCS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ESPCS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this program allow for people who are twenty or older to enroll?
"Individuals that meet the age criteria of being over 18 and under 45 are being recruited for this trial."
How many test subjects are being monitored in this experiment?
"The trial is still recruiting patients, as of the most recent update on clinicaltrials.gov. The trial was first posted on February 1st, 2020 and was last edited on February 3rd, 2020. They are looking for a total of 160 patients at a single location."
Are there any restrictions in place for who can take part in this experiment?
"Within the target age bracket of 18 to 45, this clinical trial needs 160 individuals that have undergone a cesarean section. The most important criterion that candidates must meet is as follows: being patients that have undergone scheduled Cesarean delivery."
Are there any patients you are still looking to enroll in this clinical trial?
"Yes, this clinical trial is recruiting patients as of the most recent update on clinicaltrials.gov (2/3/2020). This study was originally posted on 2/1/2020."
What is the governing body's stance on Erector Spinae Plane Block?
"Erector Spinae Plane Block is considered safe, as Phase 3 trials have both some efficacy data and multiple rounds of safety data."
Does a body of research exist for Erector Spinae Plane Block?
"There are currently 62 different clinical trials underway that are researching Erector Spinae Plane Block. 16 of those trials are in Phase 3, which is the final stage of testing before a treatment can be approved. The majority of trials for Erector Spinae Plane Block are based in Boston, Massachusetts, but there are 138 locations running trials for this treatment."
Share this study with friends
Copy Link
Messenger